首页> 美国卫生研究院文献>International Journal of Surgical Oncology >Now Later of Never: Multicenter Randomized Controlled Trial Call—Is Surgery Necessary after Atypical Breast Core Biopsy Results in Mammographic Screening Settings?
【2h】

Now Later of Never: Multicenter Randomized Controlled Trial Call—Is Surgery Necessary after Atypical Breast Core Biopsy Results in Mammographic Screening Settings?

机译:现在从此以后再也没有了:多中心随机对照试验通话-非典型乳芯穿刺活检后是否需要进行乳房X线摄影筛查设置的手术?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Breast cancer mammographic screening leads to detection of premalignant and preinvasive lesions with an increasing frequency. Nevertheless, current epidemiologic evidence indicates that the screening reduces breast cancer specific mortality, but not overall mortality in breast cancer patients. The evidence is lacking whether aggressive eradication of DCIS (preinvasive form of breast carcinoma) by surgery and radiation is of survival benefit, as long-term breast cancer specific mortality in a cohort of patients with DCIS is already in a single digit percent range. Furthermore, it is currently not known whether the aggressive surgical eradication of atypical breast lesions which fall short of diagnosis of DCIS is of any benefit for the patients. Here we propose a model for a randomized controlled trial to generate high level evidence and solve this dilemma.
机译:乳腺癌乳腺X线摄影检查导致检出恶变前和浸润前病变的频率越来越高。尽管如此,当前的流行病学证据表明,筛查可以降低乳腺癌的特定死亡率,但不能降低乳腺癌患者的整体死亡率。缺乏证据表明通过外科手术和放射线积极根除DCIS(乳腺癌的浸润前形式)是否具有生存优势,因为DCIS患者队列中长期乳腺癌的特异性死亡率已经在百分之几的范围内。此外,目前尚不明确诊断达不到DCIS的非典型乳腺病变的积极手术根除对患者是否有益。在这里,我们提出了一个随机对照试验的模型,以产生高水平的证据并解决这一难题。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号